Intercept Pharmaceuticals, Inc. ICPT
19.00 0.00 (+0.00%)
At closeNov 7, 2023, 4:00 PM EST
18.98 Day range 19.01
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 285.71M | 260.75M | 233.97M | 252.00M | 179.80M | |
| 284.73M | 259.55M | 231.62M | 247.79M | 177.28M | |
| -68.22M | -100.41M | -229.73M | -312.43M | -285.49M | |
| 221.82M | -91.43M | -274.88M | -344.68M | -309.24M | |
| 6.56 | -2.87 | -8.34 | -10.89 | -10.86 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 55.86M | 92.83M | 65.65M | 74.78M | 43.25M | |
| 553.71M | 527.02M | 580.49M | 754.89M | 509.17M | |
| 460.63M | 710.99M | 747.34M | 703.33M | 490.04M | |
| 332.67M | 539.78M | 560.58M | 532.08M | 371.25M | |
| 93.08M | -183.96M | -166.85M | 51.56M | 19.13M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -26.78M | -41.07M | -171.86M | -236.61M | -240.71M | |
| 261.85M | 70.73M | 162.82M | -188.99M | -48.07M | |
| -267.32M | 1.12M | -693.00K | 457.52M | 263.55M | |
| -568.00K | -397.00K | -3.89M | -1.14M | -167.00K | |
| -38.55M | 28.75M | -9.13M | 31.53M | -26.77M |